Plasma FGF21 concentrations are regulated by glucose independently of insulin and GLP-1 in lean, healthy humans
Background Fibroblast growth factor 21 (FGF21) treatment improves metabolic homeostasis in diverse species, including humans. Physiologically, plasma FGF21 levels increase modestly after glucose ingestion, but it is unclear whether this is mediated by glucose itself or due to a secondary effect of p...
Main Authors: | Thomas P.J. Solomon, Steven Carter, Jacob M. Haus, Kristian Karstoft, Stephanie von Holstein-Rathlou, Mette S. Nielsen, Matthew P. Gillum |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2022-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/12755.pdf |
Similar Items
-
Short‐term semaglutide treatment improves FGF21 responsiveness in primary hepatocytes isolated from high fat diet challenged mice
by: Jia Nuo Feng, et al.
Published: (2023-03-01) -
Alteration of cognitive function in overweight and obese adolescents and its relationship with serum FGF21 levels
by: HAN Rui, et al.
Published: (2024-01-01) -
Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans
by: A. L. De Sousa-Coelho, et al.
Published: (2023-08-01) -
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-06-01) -
Adhesive, injectable, and ROS-responsive hybrid polyvinyl alcohol (PVA) hydrogel co-delivers metformin and fibroblast growth factor 21 (FGF21) for enhanced diabetic wound repair
by: Hong Zhu, et al.
Published: (2022-08-01)